SCHEMBL6165634

SCHEMBL6165634

c1cc(Cc2ncco2)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.41
S1PR3 Q99500 1/20 0.41
LTA4H P09960 2/20 0.39
CYP3A4 P08684 3/20 0.38
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
CYP17A1 P05093 2/20 0.38
CYP19A1 P11511 2/20 0.38
LOXL2 Q9Y4K0 2/20 0.38
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL527670 0.83 CALM1 (0.44) S1PR1LTA4HNPC1RAB9AALDH1A1
SCHEMBL20773482 0.80 NPC1 (0.41) LOXL2NPC1TP53RAB9AHRH4
SCHEMBL20773616 0.80 NPC1 (0.44) NPC1LMNARAB9AALDH1A1MAPT
SCHEMBL15660842 0.80 CYP3A4 (0.48) CYP3A4CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL6643942 0.80 EPHX2 (0.42) CYP3A4CYP11B1CYP11B2CYP19A1NPC1
SCHEMBL10687520 0.80 ESR1 (0.48) EDNRBEDNRA
SCHEMBL7704422 0.79 CYP1B1 (0.32) EDNRBEDNRA
Biphenyl SCHEMBL28708802 0.79 RAB9A (0.47) S1PR1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL3628598 0.77 LTA4H (0.47) LTA4HNPC1RAB9ASMN1; SMN2EDNRB
SCHEMBL6165832 0.77 CYP11B1 (0.45) LTA4HCYP3A4CYP11B1CYP11B2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO disclosed